What We’re Reading, July 14, 2016: Inaccurate provider directories in California health plans; atehnahealth survey identifies low physician engagement; and opioid addiction bill will soon be law.
Inaccurate provider directories under the California Marketplace plans and commercial plans might be responsible for a major mess in the healthcare market in the state, according to a new Kaiser study published in Health Affairs. Using pseudo shoppers, the authors tried to contact 743 doctors, listed as primary care physicians, in 5 of the 19 insurance Marketplaces in California, but were able to make appointments less than 30% of the time, due to reasons including bad numbers and lack of response to messages. The study also found confusion about whether a provider was in-network or out-of-network.
Data from athenahealth: physician engagement is low across the board, and particularly in primary care. The company released results from its 2016 Physician Leadership and Engagement Index, which found that only 20% of physicians are engaged with the institutions they work for. The report was based on a survey conducted in January 2016 among 2011 practicing physicians. Overall, the survey found better engagement among male physicians and that the engagement level was higher when the practice was physician-owned or was an independent medical group or practice.
The Comprehensive Addiction and Recovery Act has passed the Senate by a margin of 90-2, following its approval in the House last week by a vote of 407-5. The Senate voted late last night to advance the bill that aims to treat those suffering from addiction to prescription painkillers and heroin. The bill, however, may not receive the $1.1 billion requested by the Obama administration. Funding authorization is expected in September once Congress is back from summer recess.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More